ÂÜÀòÂÒÂ×

Jun is responsible for the general management and business development of the company and a member of the Board of Directors. In 1999, Dr. Wang co-founded BGI, which is now widely recognized as one of world¡¯s premier research facilities committed to excellence in genome sciences. During this time, Dr. Wang managed three rounds of fundraising (about 1B$ in total), and acquired a U.S. public company, Complete Genomics. He was recognized with numerous awards and nominations, such as His Royal Highness Prince Foundation, Nature¡¯s 10 - the year in Science (2012), ¡°Fortune¡¯s 40 under 40¡± by Fortune Magazine (2013), ¡°Highly Cited Researchers¡± (2013/2014/2015/2017) by Thomson Reuters (renamed Clarivate Analytics), ¡°The 100 Most Creative People of 2017¡± by Fast Company. Dr. Wang earned a bachelor¡¯s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.